Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

AIMS: Under‐ and, especially, overdosing of replacement therapy in haemophilia A patients may be prevented by application of other morphometric variables than body weight (BW) to dose factor VIII (FVIII) concentrates. Therefore, we aimed to investigate which morphometric variables best describe inte...

Descripción completa

Detalles Bibliográficos
Autores principales: van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246536/
https://www.ncbi.nlm.nih.gov/pubmed/33232535
http://dx.doi.org/10.1111/bcp.14670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246536/
https://www.ncbi.nlm.nih.gov/pubmed/33232535
http://dx.doi.org/10.1111/bcp.14670

Ejemplares similares